As researchers race to identify new therapeutics, streamlined antibody discovery processes have never been more crucial, and the need for speed and efficiency is paramount. The development of ...

Antibody discovery research paves the way for new therapeutics. The search for the right antibody for a specific therapeutic application necessitates several iterations of antibody production and ...

Scientists from Northwestern University, USA, have recently developed a high-throughput, automated screening platform to rapidly identify anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV ...

Multiplexed, multiparameter screening assays are foundational to the drug discovery process. By collecting more information, more rapidly – whether the focus antibodies, small molecules, or phenotypic ...

The development of potent and selective monoclonal antibodies (mAbs) is a significant challenge. More than 25 antibodies have been approved for human therapy and over 240 antibodies are being ...

The presence of hepatitis B surface antibodies in the blood indicates a person is recovering from a hepatitis B virus infection. It means that their immunity to HBV is increasing. By testing a ...

A novel biomarker derived from Epstein-Barr virus (EBV) significantly improved the diagnostic accuracy for nasopharyngeal carcinoma, a large screening study from China showed. Screening with P85-Ab, ...

Antibodies are disease-fighting proteins that play a crucial role in the immune system. Antibodies recognize infectious invaders, such as bacteria and viruses, and help the body eliminate them.